J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer.
Washington state reaches a nearly $150 million settlement with Johnson & Johnson over opioid crisis
The Washington state attorney general has announced a $149.5 million settlement agreement with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role in the opioid addiction crisis.
J&J's Janssen settles with WVa for $99M in opioid lawsuit
West Virginia will receive $99 million in a settlement finalized with Johnson & Johnsonโs subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths.
Strong Q2 from J&J as pandemic-hit sales, profit recover
Johnson & Johnsonโs second-quarter profit soared 73%, thanks to strong sales growth, particularly in its medical device and diagnostics segment, as hospitals and the health care industry as a whole continue recovering from the coronavirus pandemic.
EXPLAINER: $26B opioid settlement big step, but not the end
A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant โ but it is far from tying a neat bow on the tangle of still-unresolved lawsuits surrounding the epidemic.
US opioid lawsuits on verge of settlements with 4 companies
The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion deal to settle lawsuits brought by state and local governments across the country over the toll of prescription opioids, lawyers suing on behalf of local governments said.